Lv et al. (2020) identified PSMD14 as a novel post-translational regulator of GRB2. PSMD14 could inhibit GRB2 degradation by deubiquitinating this oncoprotein in liver cancer cells (Lv et al., 2020). Here, PSMD14 is linked to liver cancer.